Home › Research › Disease mechanisms
Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis
Chin KS, Yassi N, Churilov L, Masters CL, Watson R.. Parkinsonism & related disorders, 2020-09-23
Topic: Brain proteins, microglia and lab models
Plain-language summary
Introduction Alzheimer's disease neuropathologies (amyloid-β and tau) frequently co-exist to varying degrees in Lewy body dementias (LBD), which include dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD). Objectives To investigate the prevalence of tau in DLB and PDD, and its associations with clinical outcomes. Methods We searched the major electronic databases using the search term: ("dementia with Lewy bodies" OR "diffuse Lewy body disease" OR "Lewy body variant of Alzheimer's disease") AND ("tau protein" OR "tauopathy" OR "neurofibrillary tangle"), for relevant studies which evaluated tau in LBD. Forty-nine articles met the inclusion criteria for data extraction. Where appropriate, a random-effect meta-analysis was performed to obtain pooled estimates for prevalence and risk ratios (RR) or standardized mean differences (SMD) for clinical features, diagnostic accuracy and cognition. Results Braak neurofibrillary tangle stage ≥ III was observed in 66% (n = 1511, 95%CI 60%-73%) of DLB and 52% (n = 433, 95%CI 27%-76%) of PDD at autopsy. Abnormal CSF phosphorylated-tau levels were present in 28% (n = 925, 95%CI 25%-31%) of DLB and 15% (n = 172, 95%CI 5%-24%) of PDD cases. Higher tau burden in DLB was associated with reduced likelihood of manifesting visual hallucinations (RR 0.56; 95%CI 0.40-0.77) and motor parkinsonism (RR 0.62; 95%CI 0.40-0.98), lower diagnostic accuracy of DLB during life (RR 0.49; 95%CI 0.38-0.64) and worse cognition prior to death (SMD 0.63; 95%CI 0.46-0.81). Conclusions Tau is common in LBD and may reduce clinical diagnostic accuracy in people with DLB. Prospective longitudinal studies are needed to understand the roles of co-morbid neuropathologies in Lewy body dementias.
What this study adds
Evidence grade: High
This is a pooled review of 1,511 participants. Pooling 49 articles, this review found Alzheimer-type tau tangles (Braak stage ≥ III) in 66% of people with dementia with Lewy bodies and 52% with Parkinson's disease dementia at autopsy. Reported effect size: RR 0.56; RR 0.62; RR 0.49.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Chin, K. S., Yassi, N., Churilov, L., Masters, C. L., & Watson, R. (2020). Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis. Parkinsonism & related disorders. https://doi.org/10.1016/j.parkreldis.2020.09.030
Vancouver
Chin KS, Yassi N, Churilov L, Masters CL, Watson R. Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis. Parkinsonism & related disorders. 2020. doi:10.1016/j.parkreldis.2020.09.030. PMID: 33260030.
BibTeX
@article{chin2020-33260030,
author = {Chin, K. S. and Yassi, N. and Churilov, L. and Masters, C. L. and Watson, R.},
title = {{Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis}},
journal = {Parkinsonism \& related disorders},
year = {2020},
doi = {10.1016/j.parkreldis.2020.09.030},
pmid = {33260030},
url = {https://doi.org/10.1016/j.parkreldis.2020.09.030}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results Braak neurofibrillary tangle stage ≥ III was observed in 66% (n = 1511, 95%CI 60%-73%) of DLB and 52% (n = 433, 95%CI 27%-76%) of PDD at autopsy.
- Higher tau burden in DLB was associated with reduced likelihood of manifesting visual hallucinations (RR 0.56; 95%CI 0.40-0.77) and motor parkinsonism (RR 0.62; 95%CI 0.40-0.98), lower diagnostic accuracy of DLB during life (RR 0.49; 95%CI 0.38-0.64) and worse cognition prior to death (SMD 0.63; 95%CI 0.46-0.81).
Why it matters
Pooling 49 articles, this review found Alzheimer-type tau tangles (Braak stage ≥ III) in 66% of people with dementia with Lewy bodies and 52% with Parkinson's disease dementia at autopsy. In dementia with Lewy bodies, more tau was linked to fewer hallucinations, less parkinsonism, worse cognition before death and lower accuracy of diagnosis during life. The authors conclude tau is common in these dementias and may make dementia with Lewy bodies harder to diagnose correctly during life.
Study details
- Study designmeta-analysis
- Participants1,511
- Effect sizeRR 0.56; RR 0.62; RR 0.49
- Evidence strengthHigh
How this study scored 66/100
Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Parkinsonism & related disorders) |
| Journal's citation record | 2 / 4 | Parkinsonism & Related Disorders: journal h-index 155 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 3 / 4 | 1,511 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 4 / 7 | Cited 60 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 7.5 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 2 / 6 | Cited 1.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 6 other studies in this library |
| Still being cited | 2 / 4 | Cited 36 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Rosie Watson: h-index 28 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | The University of Melbourne: institution h-index 1,342 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33260030) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 66 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 26.
Later studies that cite this one
6 studies in the alzhub library list this one in their references.
Related studies in Disease mechanisms from nearby years
Also tagged “phosphorylated”
733 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 733 tagged studies.